Specific human and Candida cellular interactions lead to controlled or persistent infection outcomes during granuloma-like formation

Infection and Immunity

Volumn 85, Issue 1, 2017, Pages

  Misme Aucouturier, Barbara ^a   Albassier, Marjorie ^a   Alvarez Rueda, Nidia ^a   Pape, Patrice Le ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Candida spp.; Granulomatous immune response; Host pathogen interactions; Persistence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CD14 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; INTERLEUKIN 10;

ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CD4 CD8 RATIO; CELL INTERACTION; CLAVISPORA LUSITANIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNGUS HYPHAE; FUNGUS ISOLATION; GRANULOMA; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; KLUYVEROMYCES MARXIANUS; NATURAL KILLER CELL; NEGATIVE FEEDBACK; NEUTROPHIL COUNT; NORMAL HUMAN; PERSISTENT INFECTION; PICHIA KUDRIAVZEVII; PRIORITY JOURNAL; CANDIDA; CANDIDIASIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; IMMUNOLOGY; MICROBIOLOGY;

CANDIDA; CANDIDIASIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GRANULOMA; HUMANS; HYPHAE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85009090952     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00807-16     Document Type: Article

References (78)

1. Yapar N. 2014. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag 10:95-105.
2. Arendrup MC. 2010. Epidemiology of invasive candidiasis. Curr Opin Crit Care 16:445-452. https://doi.org/10.1097/MCC.0b013e32833e84d2.
3. Liu MB, Xu SR, He Y, Deng GH, Sheng HF, Huang XM, Ouyang CY, Zhou HW. 2013. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis. PLoS One 8:e79812. https://doi.org/10.1371/journal.pone.0079812.
4. Mason KL, Erb Downward JR, Mason KD, Falkowski NR, Eaton KA, Kao JY, Young VB, Huffnagle GB. 2012. Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broadspectrum antibiotic therapy. Infect Immun 80:3371-3380. https://doi.org/10.1128/IAI.00449-12.
5. Martinez-álvarez JA, Perez-Garcia LA, Flores-Carreon A, Mora-Montes HM. 2014 The immune response against Candida spp. and Sporothrix schenckii. Rev Iberoam Micol 31:62-66. https://doi.org/10.1016/j.riam.2013.09.015.
6. Mora-Montes HM, McKenzie C, Bain JM, Lewis LE, Erwig LP, Gow NA. 2012. Interactions between macrophages and cell wall oligosaccharides of Candida albicans. Methods Mol Biol 845:247-260. https://doi.org/10.1007/978-1-61779-539-8_16.
7. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. 2012. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10:112-122.
8. Mora-Montes HM, Netea MG, Ferwerda G, Lenardon MD, Brown GD, Mistry AR, Kullberg BJ, O'Callaghan CA, Sheth CC, Odds FC, Brown AJ, Munro CA, Gow NA. 2011. Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect Immun 79:1961-1970. https://doi.org/10.1128/IAI.01282-10.
9. Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, Dupont H, Montravers P, Perrigault PF, Constantin JM, Guillemot D, Azoulay E, Lortholary O, Bensoussan C, Timsit JF, Amar CSG. 2016. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Ann Intensive Care 6:2. https://doi.org/10.1186/s13613-015-0103-7.
10. Maubon D, Garnaud C, Calandra T, Sanglard D, Cornet M. 2014. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med 40:1241-1255. https://doi.org/10.1007/s00134-014-3404-7.
11. Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Tumbarello M. 2013. Epidemiology, species distribution, anti-fungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51:4167-4172. https://doi.org/10.1128/JCM.01998-13.
12. Meis JF, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE. 1999. Candida dubliniensis candidemia in patients with chemotherapyinduced neutropenia and bone marrow transplantation. Emerg Infect Dis 5:150-153. https://doi.org/10.3201/eid0501.990119.
13. Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL, Jr, Noverr M. 2016. Candida albicans pathogenesis: fitting within the "hostmicrobe damage response framework." Infect Immun https://doi.org/10.1128/IAI.00469-16.
14. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. 2016. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:409-417. https://doi.org/10.1093/cid/civ1194.
15. Spellberg B. 2008. Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge. PLoS Pathog 4:e38. https://doi.org/10.1371/journal.ppat.0040038.
16. Maher CO, Dunne K, Comerford R, O'Dea S, Loy A, Woo J, Rogers TR, Mulcahy F, Dunne PJ, Doherty DG. 2015. Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by Vdelta1 T cells. J Immunol 194:5953-5960. https://doi.org/10.4049/jimmunol.1403066.
17. Voigt J, Hunniger K, Bouzani M, Jacobsen ID, Barz D, Hube B, Loffler J, Kurzai O. 2014. Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity. J Infect Dis 209:616-626. https://doi.org/10.1093/infdis/jit574.
18. Quintin J, Voigt J, van der Voort R, Jacobsen ID, Verschueren I, Hube B, Giamarellos-Bourboulis EJ, van der Meer JW, Joosten LA, Kurzai O, Netea MG. 2014. Differential role of NK cells against Candida albicans infection in immunocompetent or immunocompromised mice. Eur J Immunol 44:2405-2414. https://doi.org/10.1002/eji.201343828.
19. Fidel PL, Jr. 2011. Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis. Adv Dent Res 23:45-49. https://doi.org/10.1177/0022034511399284.
20. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009 Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299-311. https://doi.org/10.1084/jem.20081463.
21. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-2279. https://doi.org/10.1084/jem.20061308.
22. Guarner J, Brandt ME. 2011. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 24:247-280. https://doi.org/10.1128/CMR.00053-10.
23. Albano D, Bosio G, Bertoli M, Petrilli G, Bertagna F. 2016. Hepatosplenic candidiasis detected by (18)F-FDG-PET/CT. Asia Ocean J Nucl Med Biol 4:106-108.
24. Hoarau G, Kerdraon O, Lagree M, Vinchon M, Francois N, Dubos F, Sendid B. 2013. Detection of (1, 3)-beta-D-glucans in situ in a Candida albicans brain granuloma. J Infect 67:622-624. https://doi.org/10.1016/j.jinf.2013.08.002.
25. Song Z, Papanicolaou N, Dean S, Bing Z. 2012. Localized candidiasis in kidney presented as a mass mimicking renal cell carcinoma. Case Rep Infect Dis 2012:953590.
26. Ogura M, Kagami S, Nakao M, Kono M, Kanetsuna Y, Hosoya T. 2012. Fungal granulomatous interstitial nephritis presenting as acute kidney injury diagnosed by renal histology including PCR assay. Clin Kidney J 5:459-462. https://doi.org/10.1093/ckj/sfs103.
27. Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP. 2000. Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis. Infect Dis Clin North Am 14:721-739. https://doi.org/10.1016/S0891-5520(05)70128-8.
28. Cheng S, Clancy CJ, Hartman DJ, Hao B, Nguyen MH. 2014. Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses. Infect Immun 82:3015-3022. https://doi.org/10.1128/IAI.00062-14.
29. Castillo L, MacCallum DM, Brown AJ, Gow NA, Odds FC. 2011. Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants. Infect Immun 79:146-152. https://doi.org/10.1128/IAI.01004-10.
30. MacCallum DM. 2009. Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. FEMS Yeast Res 9:1111-1122. https://doi.org/10.1111/j.1567-1364.2009.00576.x.
31. Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. 2015. Immune defence against Candida fungal infections. Nat Rev Immunol 15:630-642. https://doi.org/10.1038/nri3897.
32. Tóth A, Csonka K, Jacobs C, Vagvolgyi C, Nosanchuk JD, Netea MG, Gacser A. 2013. Candida albicans and Candida parapsilosis induce different T-cell responses in human peripheral blood mononuclear cells. J Infect Dis 208:690-698. https://doi.org/10.1093/infdis/jit188.
33. Dementhon K, El-Kirat-Chatel S, Noel T. 2012. Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes. PLoS One 7:e32621. https://doi.org/10.1371/journal.pone.0032621.
34. Svobodová E, Staib P, Losse J, Hennicke F, Barz D, Jozsi M. 2012. Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils. J Immunol 189:2502-2511. https://doi.org/10.4049/jimmunol.1200185.
35. Nagy I, Filkor K, Nemeth T, Hamari Z, Vagvolgyi C, Gacser A. 2011. In vitro interactions of Candida parapsilosis wild type and lipase deficient mutants with human monocyte derived dendritic cells. BMC Microbiol 11:122. https://doi.org/10.1186/1471-2180-11-122.
36. Neumann AK, Jacobson K. 2010. A novel pseudopodial component of the dendritic cell anti-fungal response: the fungipod. PLoS Pathog 6:e1000760. https://doi.org/10.1371/journal.ppat.1000760.
37. Guirado E, Mbawuike U, Keiser TL, Arcos J, Azad AK, Wang SH, Schlesinger LS. 2015. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. mBio 6:e02537-14. https://doi.org/10.1128/mBio.02537-14.
38. Hogan LH, Wang M, Suresh M, Co DO, Weinstock JV, Sandor M. 2002. CD4+ TCR repertoire heterogeneity in Schistosoma mansoni-induced granulomas. J Immunol 169:6386-6393. https://doi.org/10.4049/jimmunol.169.11.6386.
39. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435. https://doi.org/10.1126/science.280.5368.1432.
40. Alvarez-Rueda N, Albassier M, Allain S, Deknuydt F, Altare F, Le Pape P. 2012 First human model of in vitro Candida albicans persistence within granuloma for the reliable study of host-fungi interactions. PLoS One 7:e40185. https://doi.org/10.1371/journal.pone.0040185.
41. Romani L. 2011. Immunity to fungal infections. Nat Rev Immunol 11: 275-288. https://doi.org/10.1038/nri2939.
42. Gil ML, Gozalbo D. 2009. Role of Toll-like receptors in systemic Candida albicans infections. Front Biosci (Landmark ed) 14:570-582.
43. Thompson DS, Carlisle PL, Kadosh D. 2011. Coevolution of morphology and virulence in Candida species. Eukaryot Cell 10:1173-1182. https://doi.org/10.1128/EC.05085-11.
44. Tóth R, Alonso MF, Bain JM, Vagvolgyi C, Erwig LP, Gacser A. 2015. Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response. Front Microbiol 6:1102.
45. Lewis RE. 2009. Overview of the changing epidemiology of candidemia. Curr Med Res Opin 25:1732-1740.
46. Bhavanam S, Rayat GR, Keelan M, Kunimoto D, Drews SJ. 2016. Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models. Future Microbiol 11:1073-1089. https://doi.org/10.2217/fmb-2016-0005.
47. Subbian S, Tsenova L, Kim MJ, Wainwright HC, Visser A, Bandyopadhyay N, Bader JS, Karakousis PC, Murrmann GB, Bekker LG, Russell DG, Kaplan G. 2015. Lesion-specific immune response in granulomas of patients with pulmonary tuberculosis: a pilot study. PLoS One 10:e0132249. https://doi.org/10.1371/journal.pone.0132249.
48. Gideon HP, Phuah J, Myers AJ, Bryson BD, Rodgers MA, Coleman MT, Maiello P, Rutledge T, Marino S, Fortune SM, Kirschner DE, Lin PL, Flynn JL. 2015. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro-and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog 11:e1004603. https://doi.org/10.1371/journal.ppat.1004603.
49. Girgis NM, Gundra UM, Ward LN, Cabrera M, Frevert U, Loke P. 2014. Ly6C(high) monocytes become alternatively activated macrophages in schistosome granulomas with help from CD4+ cells. PLoS Pathog 10: e1004080. https://doi.org/10.1371/journal.ppat.1004080.
50. Aoun J, Habib R, Charaffeddine K, Taraif S, Loya A, Khalifeh I. 2014. Caseating granulomas in cutaneous leishmaniasis. PLoS Negl Trop Dis 8:e3255. https://doi.org/10.1371/journal.pntd.0003255.
51. Donaghy L, Cabillic F, Corlu A, Rostan O, Toutirais O, Guguen-Guillouzo C, Guiguen C, Gangneux JP. 2010. Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment. PLoS Negl Trop Dis 4:e703. https://doi.org/10.1371/journal.pntd.0000703.
52. Heninger E, Hogan LH, Karman J, Macvilay S, Hill B, Woods JP, Sandor M. 2006 Characterization of the Histoplasma capsulatum-induced granuloma. J Immunol 177:3303-3313. https://doi.org/10.4049/jimmunol.177.5.3303.
53. Fitzpatrick DA, O'Gaora P, Byrne KP, Butler G. 2010. Analysis of gene evolution and metabolic pathways using the Candida Gene Order Browser. BMC Genomics 11:290. https://doi.org/10.1186/1471-2164-11-290.
54. Gazendam RP, van Hamme JL, Tool AT, van Houdt M, Verkuijlen PJ, Herbst M, Liese JG, van de Veerdonk FL, Roos D, van den Berg TK, Kuijpers TW. 2014. Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. Blood 124:590-597. https://doi.org/10.1182/blood-2014-01-551473.
55. Lionakis MS, Netea MG. 2013. Candida and host determinants of susceptibility to invasive candidiasis. PLoS Pathog 9:e1003079. https://doi.org/10.1371/journal.ppat.1003079.
56. Kenno S, Perito S, Mosci P, Vecchiarelli A, Monari C. 2016. Autophagy and reactive oxygen species are involved in neutrophil extracellular traps release induced by C. albicans morphotypes. Front Microbiol 7:879.
57. McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P. 2012. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12:324-333. https://doi.org/10.1016/j.chom.2012.06.011.
58. Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, Pittman K, Asaduzzaman M, Wu K, Meijndert HC, Malawista SE, de Boisfleury Chevance A, Zhang K, Conly J, Kubes P. 2012. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med 18:1386-1393. https://doi.org/10.1038/nm.2847.
59. Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, Tesselaar K, Koenderman L. 2010. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116:625-627. https://doi.org/10.1182/blood-2010-01-259028.
60. Kim J, Kim DS, Lee YS, Choi NG. 2011. Fungal urinary tract infection in burn patients with long-term foley catheterization. Korean J Urol 52: 626-631. https://doi.org/10.4111/kju.2011.52.9.626.
61. Gazendam RP, van de Geer A, van Hamme JL, Tool AT, van Rees DJ, Aarts CE, van den Biggelaar M, van Alphen F, Verkuijlen P, Meijer AB, Janssen H, Roos D, van den Berg TK, Kuijpers TW. 2016. Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components. Haematologica https://doi.org/10.3324/haematol.2015.136630.
62. Espinosa V, Jhingran A, Dutta O, Kasahara S, Donnelly R, Du P, Rosenfeld J, Leiner I, Chen CC, Ron Y, Hohl TM, Rivera A. 2014. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog 10:e1003940. https://doi.org/10.1371/journal.ppat.1003940.
63. Ramirez-Ortiz ZG, Means TK. 2012. The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans). Virulence 3:635-646. https://doi.org/10.4161/viru.22295.
64. Sandilands GP, Ahmed Z, Perry N, Davison M, Lupton A, Young B. 2005. Cross-linking of neutrophil CD11b results in rapid cell surface expression of molecules required for antigen presentation and T-cell activation. Immunology 114:354-368. https://doi.org/10.1111/j.1365-2567.2004.02114.x.
65. Pahar B, Lackner AA, Veazey RS. 2006. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. Eur J Immunol 36:583-592. https://doi.org/10.1002/eji.200535520.
66. Naseem S, Frank D, Konopka JB, Carpino N. 2015. Protection from systemic Candida albicans infection by inactivation of the Sts phosphatases. Infect Immun 83:637-645. https://doi.org/10.1128/IAI.02789-14.
67. Jones-Carson J, Vazquez-Torres FA, Balish E. 1997. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans. J Immunol 158:4328-4335.
68. Beno DW, Stover AG, Mathews HL. 1995. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol 154:5273-5281.
69. Milner JD, Sandler NG, Douek DC. 2010. Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections. Curr Opin HIV AIDS 5:179-183. https://doi.org/10.1097/COH.0b013e328335ed3e.
70. Delgado AC, de Jesus Pedro R, Aoki FH, Resende MR, Trabasso P, Colombo AL, de Oliveira MS, Mikami Y, Moretti ML. 2009. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. Clin Microbiol Infect 15:364-371. https://doi.org/10.1111/j.1469-0691.2009.02707.x.
71. Romani L, Mencacci A, Cenci E, Spaccapelo R, Mosci P, Puccetti P, Bistoni F. 1993. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccineinduced resistance. J Immunol 150:925-931.
72. Romani L, Cenci E, Menacci A, Bistoni F, Puccetti P. 1995. T helper cell dichotomy to Candida albicans: implications for pathology, therapy, and vaccine design. Immunol Res 14:148-162. https://doi.org/10.1007/BF02918174.
73. Ghaleb M, Hamad M, Abu-Elteen KH. 2003. Vaginal T lymphocyte population kinetics during experimental vaginal candidosis: evidence for a possible role of CD8+ T cells in protection against vaginal candidosis. Clin Exp Immunol 131:26-33. https://doi.org/10.1046/j.1365-2249.2003.02032.x.
74. Paulovicová E, Machova E, Tulinska J, Bystricky S. 2007. Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate. Int Immunopharmacol 7:1325-1333. https://doi.org/10.1016/j.intimp.2007.05.014.
75. Martinez-Gallo M, Puy C, Ruiz-Hernandez R, Rodriguez-Arias JM, Bofill M, Nomdedeu JF, Cigudosa JC, Rodriguez-Sanchez JL, de la Calle-Martin O. 2008 Severe and recurrent episodes of bronchiolitis obliterans organising pneumonia associated with indolent CD4+ CD8+ T-cell leukaemia. Eur Respir J 31:1368-1372. https://doi.org/10.1183/09031936.00061907.
76. Ahmad E, Fatima MT, Saleemuddin M, Owais M. 2012. Plasma beads loaded with Candida albicans cytosolic proteins impart protection against the fungal infection in BALB/c mice. Vaccine 30:6851-6858. https://doi.org/10.1016/j.vaccine.2012.09.010.
77. Martinez-Martinez L, Martinez-Saavedra MT, Fuentes-Prior P, Barnadas M, Rubiales MV, Noda J, Badell I, Rodriguez-Gallego C, de la Calle-Martin O. 2015. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-gamma-mediated responses in chronic mucocutaneous candidiasis. Mol Immunol 68: 597-605. https://doi.org/10.1016/j.molimm.2015.09.014.
78. Barelle CJ, Manson CL, MacCallum DM, Odds FC, Gow NA, Brown AJ. 2004 GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast 21:333-340. https://doi.org/10.1002/yea.1099.